198
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Control of Home Blood Pressure with an Amlodipine- or Losartan-Based Regimen and Progression of Carotid Artery Intima-media Thickness in Hypertensive Patients: The HOSP Substudy

, , , , , , , , & show all
Pages 279-284 | Received 07 Oct 2012, Accepted 07 Dec 2012, Published online: 26 Mar 2013

REFERENCES

  • Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective Studies Collaboration: age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903–1913.
  • Kokubo Y, Nakamura S, Okamura TRelationship between blood pressure category and incidence of stroke and myocardial infarction in an urban Japanese population with and without chronic kidney disease: the Suita Study. Stroke 2009; 40:2674–2679.
  • Turnbull F. Blood Pressure Lowering Treatment Trialists’ Collaboration: effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003; 362:1527–1535.
  • Arima H, Chalmers J, Woodward MPROGRESS Collaborative Group: lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens 2006; 24:1201–1208.
  • Tsunoda S, Kawano Y, Horio T, Okuda N, Takishita S. Relationship between home blood pressure and longitudinal changes in target organ damage in treated hypertensive patients. Hypertens Res 2002; 25:167–173.
  • Bobrie G, Chatellier G, Genes NCardiovascular prognosis of “masked hypertension” detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291:1342–1349.
  • Ohkubo T, Imai Y, Tsuji IHome blood pressure measurement has a strong predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohaasama, Japan. J Hypertens 1998; 16:971–975.
  • Sega R, Facchetti R, Bombelli MPrognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population. Follow-up results from the Pressioni Arteriose Monitorate e Loro Assocciazioni (PAMELA) study. Circulation 2005; 111:1777–1783.
  • Hara A, Tanaka K, Ohkubo TAmbulatory versus home versus clinic blood pressure. The association with subclinical cerebrovascular disease: the Ohasama study. Hypertension 2012; 59:22–28.
  • Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med 1993; 153:598–615.
  • Pasty BM, Furberg CD, Kuller LHAssociation between blood pressure levels and the risk of myocardial infarction, stroke, and total mortality. Arch Intern Med 2001; 161:1183–1192.
  • Millar-Craig MW, Bishop CN, Raffery EB. Circadian variation of blood pressure. Lancet 1978; i:795–797.
  • Kawano Y. Diurnal blood pressure variation and related behavioral factors. Hypertens Res 2011; 34:281–285.
  • Mullaer JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989; 79:733–743.
  • Asayama K, Ohkubo T, Kikuya MPrediction of stroke by home “morning” versus “evening” blood pressure values: the Ohasama study. Hypertension 2006; 48:737–743.
  • Metoki H, Ohkubo T, Kikuya MPrognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study. Hypertension 2006; 47:149–154.
  • Kario K, Pickering TG, Umeda YMorning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives. A prospective study. Circulation 2003; 107:1401–1406.
  • Kawano Y, Mannami T, Saitoh DHypertension control based on home systolic pressure (HOSP): study design and interim report. J Hypertens 2002; 20(suppl 4):S162.
  • Kawano Y, Horio T, Kamide K, Iwashima Y, Yoshihara F, Nakamura S. Blood pressure and medication during long-term antihypertensive therapy based on morning home SBP in hypertensive patients: Hypertension Control Based on Home Systolic Pressure (HOSP) substudy. Clin Exp Hypertens 2010; 32:239–243.
  • Takiuchi S, Kamide K, Miwa YDiagnostic value of carotid intima-media thickness and plaque score for predicting target organ damage in patients with essential hypertension. J Hum Hypertens 2004; 18:17–23.
  • Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation 1997; 96:1432–1437.
  • Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke 2006; 37:87–92.
  • Chambless LE, Heiss G, Folson ARAssociation of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) study, 1987–1993. Am J Epidemiol 1997; 146:483–494.
  • Tropeano AI, Saleh N, Hawajiri N, Macqquin-Mavier I, Maison P. Do all antihypertensive drugs improve carotid intima-media thickness? A network meta-analysis of randomized controlled trials. Fundam Clin Pharmacol 2011; 25:395–404.
  • Cuspidi C, Negri F, Giudici V, Capra A, Sala C. Effects of antihypertensive drugs on carotid intima-media thickness: focus on angiotensin II receptor blockers. A review of randomized, controlled trials. Integr Blood Press Control 2009; 2:1–8.
  • Paul J, Shaw K, Dasgupta S, Ghosh MK. Measurement of intima media thickness of carotid artery by B-mode ultrasound in healthy people of India and Bangladesh, and relation of age and sex with carotid artery intima media thickness: an observational study. J Cardiovasc Dis Res 2012; 3:128–131.
  • Howard G, Sharrett AR, Heiss GCarotid artery intima-medial thickness distribution in general populations as evaluated by B-mode ultrasound. Stroke 1993; 24:1297–1304.
  • Puato M, Palatini P, Zanardo MIncrease in carotid intima-media thickness in grade I hypertensive subjects. White-coat versus sustained hypertension. Hypertension 2006; 51:1300–1305.
  • Vasunta RL, Kesäniemi YA, Ylitalo A, Ukkola O. Nondipping pattern and carotid atherosclerosis in a middle-aged population: OPERA study. Am J Hypertens 2012; 25:60–66.
  • Kawano Y, Horio T, Kamide KLong-term effects of strict and modest control of home blood pressure with amlodipine- or losartan-based regimen on urinary albumin excretion in hypertensive patients: HOSP substudy. J Hypertens 2006; 24(suppl 6):343.
  • Asayama K, Ohkubo T, Metoki HCardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure. Hypertens Res 2012; 35:1102–1110.
  • Zhang X, Hintze TH. Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent. Circulation 1998; 95:576–580.
  • Stepien O, Gogusev J, Zhu DLAmlodipine inhibition of serum-, thrombin-, or fibroblast growth factor-induced vascular smooth-muscle cell proliferation. J Cardiovasc Pharmacol 1998; 31:786–793.
  • Kaschina E, Unger T. Angiotensin AT1/AT2 receptors: regulation, signaling and function. Blood Press 2003; 12:70–88.
  • Keaney JF. Oxidative stress and the vascular wall NADPH oxidases take center stage. Circulation 2005; 112:2585–2588.
  • Ikeda H, Minamikawa J, Nakamura YComparison of effects of amlodipine and angiotensin receptor blockers on the intima-media thickness of carotid arterial wall (AAA study: amlodipine vs. ARB in atherosclerosis study). Diabetes Res Clin Pract 2009; 83:50–53.
  • Straton AV, Chapman JN, Mayet JEffects of blood pressure lowering with amlodipine or lisinopril on vascular structure of the common carotid artery. Clin Sci 2001; 101:455–464.
  • Terpstra WF, May JF, Smit AJEffects of amlodipine and lisinopril on intima-media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial). J Hypertens 2004; 22:1309–1316.
  • Wang JG, Staessen JA, Li YCarotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials. Stroke 2006; 37:1933–1940.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.